Zobrazeno 1 - 8
of 8
pro vyhledávání: '"I. Yu. Zinchuk"'
Autor:
R. I. Yagudina, I. Yu. Zinchuk
Publikováno v:
Фармакоэкономика, Vol 6, Iss 4, Pp 7-12 (2015)
based on the clinical study FENOC, indicated that there is no significant difference in efficacy AICC and Eptacog alfa therapy in patients susceptible to this treatment. An analysis of the direct and indirect costs shows that the costs of the annual
Externí odkaz:
https://doaj.org/article/509835e8a2674fc4a9c3cb3fb5aeb14d
Autor:
A. Yu. Kulikov, I. Yu. Zinchuk
Publikováno v:
Фармакоэкономика, Vol 6, Iss 3, Pp 17-22 (2015)
Based on meta-analysis dates found, that the effectiveness of neuroprotective drugs and placebo are not differences or has not statistically significant relative placebo. The cost minimization analysis showed that only Cytoflavin and Tserakson, by re
Externí odkaz:
https://doaj.org/article/6525178a697c45d39b38d7842a560f50
Publikováno v:
Фармакоэкономика, Vol 5, Iss 1, Pp 4-9 (2015)
Cost of illness is one of the basic methods of pharmacoeconomical estimation and in substance consists in calculation of the expenses connected any given disease, without notice of effectiveness of therapy. Cost of illness analysis is a useful tool f
Externí odkaz:
https://doaj.org/article/c030ea432bbe4de98b12428e2bc6352b
Autor:
R. I. Yagudina, I. Yu. Zinchuk
Publikováno v:
Фармакоэкономика, Vol 6, Iss 1, Pp 11-15 (2015)
To provide pharmacoeconomic evaluation of diagnostics of tuberculosis infection (TI) with Allergen tuberculosis recombinant (CFP10-ESAT6) and Allergen tuberculosis purified liquid in the standard dilution for intradermal use (PPD RT 23 SSI). The «co
Externí odkaz:
https://doaj.org/article/3ac6c0f044ed44f1a0ab0df4eba3ce98
Autor:
R. I. Yagudina, I. Yu. Zinchuk
Publikováno v:
Фармакоэкономика, Vol 6, Iss 3, Pp 31-35 (2015)
Based on a clinical study BCIRG 001 (Martin M., Mackey J., Pienkowski T.) and as an outcome of Markov simulation it was determined that the use of 6DAC for adjuvant therapy in 10 year horizon of research allows to increase the disease-free survival b
Externí odkaz:
https://doaj.org/article/8dbcdda68d314d65a41758cdeb38fcce
Autor:
I. Yu. Zinchuk, V. N. Amirdzhanova
Publikováno v:
Научно-практическая ревматология, Vol 52, Iss 3, Pp 331-335 (2014)
The paper reviews data on the incidence of rheumatoid arthritis, disability, and the cost of treatment, including thera- py with biological agents.
Externí odkaz:
https://doaj.org/article/f8d32330ff5c41c887fb7c3b51b68634
Autor:
I. Yu. Zinchuk, A. Yu. Kulikov
Publikováno v:
Pharmacoeconomics: theory and practice. 3:20-24
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::05a901c0864e031b024f9ca81f82c921
https://doi.org/10.30809/phe.3.2015.9
https://doi.org/10.30809/phe.3.2015.9
Publikováno v:
Pharmacoeconomics: theory and practice. 2:25-28
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::b4b4cafac9fbe4d26bd884d16aeb9b81
https://doi.org/10.30809/phe.1.2014.46
https://doi.org/10.30809/phe.1.2014.46